바카라 필승법What's New

News

2024/11/01
Presentation of a global phase II clinical study of a novel ROS1 inhibitor, taletrectinib, in patients with advancedROS1-positive Non-Small Cell Lung Cancer.
2024/10/10
Annual update has been made to our Sustainability site.
2024/05/08
Received ‘AA’ for 바카라 필승법 first time in MSCI ESG Ratings
PageTop
Our Business
R&D
Stock Informati에볼루션 바카라
바카라 룰untry & Region
Stock Informati바카라
Integrated report